"Medroxyprogesterone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
(6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator.
| Descriptor ID |
D008525
|
| MeSH Number(s) |
D04.210.500.745.745.654.829.395.700
|
| Concept/Terms |
Medroxyprogesterone- Medroxyprogesterone
- Methylhydroxyprogesterone
- 17 alpha-Hydroxy-6 alpha-Methylprogesterone
- 17 alpha Hydroxy 6 alpha Methylprogesterone
|
Below are MeSH descriptors whose meaning is more general than "Medroxyprogesterone".
Below are MeSH descriptors whose meaning is more specific than "Medroxyprogesterone".
This graph shows the total number of publications written about "Medroxyprogesterone" by people in this website by year, and whether "Medroxyprogesterone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Medroxyprogesterone" by people in Profiles.
-
Acute mountain sickness, vitamin C, free radicals, and HIF-1alpha. Wilderness Environ Med. 2005; 16(3):172-3.
-
Membrane-initiated steroid signaling (MISS): genomic steroid action starts at the plasma membrane. J Steroid Biochem Mol Biol. 2003 May; 85(1):9-23.
-
Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol. 1997 May; 176(5):1017-25.
-
Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women. Lancet. 1991 Mar 09; 337(8741):612.
-
Sequential cyclic combined hormonal therapy for metastatic breast cancer. Cancer. 1989 Sep 01; 64(5):1002-6.
-
Clinical trial of high-dose oral medroxyprogesterone acetate in the treatment of metastatic breast cancer and review of the literature. Cancer. 1988 Jun 01; 61(11):2161-7.
-
The treatment of retroperitoneal fibromatosis with medroxyprogesterone acetate. Obstet Gynecol. 1987 Sep; 70(3 Pt 2):502-4.
-
Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer. Breast Cancer Res Treat. 1985; 5(3):321-6.
-
Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay. Breast Cancer Res Treat. 1985; 6(3):229-35.
-
The role of progestins in the treatment of breast cancer. Semin Oncol. 1983 Dec; 10(4 Suppl 4):7-10.